331 related articles for article (PubMed ID: 31877123)
41. Muscle ERRγ mitigates Duchenne muscular dystrophy via metabolic and angiogenic reprogramming.
Matsakas A; Yadav V; Lorca S; Narkar V
FASEB J; 2013 Oct; 27(10):4004-16. PubMed ID: 23781095
[TBL] [Abstract][Full Text] [Related]
42. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy.
Acharyya S; Villalta SA; Bakkar N; Bupha-Intr T; Janssen PM; Carathers M; Li ZW; Beg AA; Ghosh S; Sahenk Z; Weinstein M; Gardner KL; Rafael-Fortney JA; Karin M; Tidball JG; Baldwin AS; Guttridge DC
J Clin Invest; 2007 Apr; 117(4):889-901. PubMed ID: 17380205
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of microRNA-92a increases blood vessels and satellite cells in skeletal muscle but does not improve duchenne muscular dystrophy-related phenotype in mdx mice.
Verma M; Asakura Y; Asakura A
Muscle Nerve; 2019 May; 59(5):594-602. PubMed ID: 30698289
[TBL] [Abstract][Full Text] [Related]
44. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition.
Tanihata J; Nagata T; Ito N; Saito T; Nakamura A; Minamisawa S; Aoki Y; Ruegg UT; Takeda S
Biochem Biophys Res Commun; 2018 Oct; 505(1):51-59. PubMed ID: 30236982
[TBL] [Abstract][Full Text] [Related]
45. Zidovudine ameliorates pathology in the mouse model of Duchenne muscular dystrophy via P2RX7 purinoceptor antagonism.
Al-Khalidi R; Panicucci C; Cox P; Chira N; Róg J; Young CNJ; McGeehan RE; Ambati K; Ambati J; Zabłocki K; Gazzerro E; Arkle S; Bruno C; Górecki DC
Acta Neuropathol Commun; 2018 Apr; 6(1):27. PubMed ID: 29642926
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy.
Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F
Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862
[TBL] [Abstract][Full Text] [Related]
47. HIF activation and VEGF overexpression are coupled with ZO-1 up-phosphorylation in the brain of dystrophic mdx mouse.
Nico B; Mangieri D; Crivellato E; Longo V; De Giorgis M; Capobianco C; Corsi P; Benagiano V; Roncali L; Ribatti D
Brain Pathol; 2007 Oct; 17(4):399-406. PubMed ID: 17784876
[TBL] [Abstract][Full Text] [Related]
48. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy.
Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC
Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069
[TBL] [Abstract][Full Text] [Related]
49. Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy.
Mucha O; Podkalicka P; Kaziród K; Samborowska E; Dulak J; Łoboda A
Skelet Muscle; 2021 Sep; 11(1):21. PubMed ID: 34479633
[TBL] [Abstract][Full Text] [Related]
50. The microRNA miR-133b functions to slow Duchenne muscular dystrophy pathogenesis.
Taetzsch T; Shapiro D; Eldosougi R; Myers T; Settlage RE; Valdez G
J Physiol; 2021 Jan; 599(1):171-192. PubMed ID: 32991751
[TBL] [Abstract][Full Text] [Related]
51. What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?
Manning J; O'Malley D
J Muscle Res Cell Motil; 2015 Apr; 36(2):155-67. PubMed ID: 25669899
[TBL] [Abstract][Full Text] [Related]
52. Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse.
Nico B; Corsi P; Ria R; Crivellato E; Vacca A; Roccaro AM; Mangieri D; Ribatti D; Roncali L
Neuroscience; 2006 Jul; 140(3):835-48. PubMed ID: 16650610
[TBL] [Abstract][Full Text] [Related]
53. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10.
Nitahara-Kasahara Y; Hayashita-Kinoh H; Chiyo T; Nishiyama A; Okada H; Takeda S; Okada T
Hum Mol Genet; 2014 Aug; 23(15):3990-4000. PubMed ID: 24659498
[TBL] [Abstract][Full Text] [Related]
54. Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.
Fajardo VA; Chambers PJ; Juracic ES; Rietze BA; Gamu D; Bellissimo C; Kwon F; Quadrilatero J; Russell Tupling A
Hum Mol Genet; 2018 Dec; 27(23):4094-4102. PubMed ID: 30137316
[TBL] [Abstract][Full Text] [Related]
55. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
56. Beneficial effect of mechanical stimulation on the regenerative potential of muscle-derived stem cells is lost by inhibiting vascular endothelial growth factor.
Beckman SA; Chen WC; Tang Y; Proto JD; Mlakar L; Wang B; Huard J
Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):2004-12. PubMed ID: 23723372
[TBL] [Abstract][Full Text] [Related]
57. Mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for duchenne muscular dystrophy.
Ahmad A; Brinson M; Hodges BL; Chamberlain JS; Amalfitano A
Hum Mol Genet; 2000 Oct; 9(17):2507-15. PubMed ID: 11030755
[TBL] [Abstract][Full Text] [Related]
58. Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.
Ponnusamy S; Sullivan RD; You D; Zafar N; He Yang C; Thiyagarajan T; Johnson DL; Barrett ML; Koehler NJ; Star M; Stephenson EJ; Bridges D; Cormier SA; Pfeffer LM; Narayanan R
Hum Mol Genet; 2017 Jul; 26(13):2526-2540. PubMed ID: 28453658
[TBL] [Abstract][Full Text] [Related]
59. A novel rabbit model of Duchenne muscular dystrophy generated by CRISPR/Cas9.
Sui T; Lau YS; Liu D; Liu T; Xu L; Gao Y; Lai L; Li Z; Han R
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29871865
[TBL] [Abstract][Full Text] [Related]
60. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
Bozycki L; Łukasiewicz K; Matryba P; Pikula S
Skelet Muscle; 2018 Jul; 8(1):21. PubMed ID: 30025544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
